Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-<i>β</i>1/Smad Signaling Pathway

<div>Masson staining of lung tissue from mice in each group (400-fold, scale bar = 50 <i>μ</i>m). NC, normal control group; BLM, bleomycin-induced systemic sclerosis model group; PESV-L, low-dose PESV intervention group; PESV-M, medium-dose PESV intervention group; PESV-H, high-dose PESV intervention group; DXM, dexamethasone intervention group.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-<i>β</i>1/Smad Signaling Pathway 

Figure 2 | Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-β1/Smad Signaling Pathway 